The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global blood warmer devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
Blood warmer devices are used to deliver peripheral warmth to the arterial piping for keeping blood or other fluids under warm conditions throughout transfusion. These devices comprise a power cord, mounting unit, and a sterilized intravenous (IV) set mounted between solution bags and the patient line. They range from simple coiled tubing in a warming bath to sophisticated rapid transfusion devices. At present, advanced warming devices are gaining traction worldwide as they utilize countercurrent heat exchange or microwave technology. Consequently, they find application in emergency settings, operating rooms, and intensive care units (ICUs) to provide warm fluid to patients with hypothermia or other rare conditions.
On account of the rising number of coronavirus disease (COVID-19) cases, the need for infusion therapies is increasing. This represents one of the major factors positively influencing the demand for blood warmer devices to bring fluids to body temperature, encourage faster patient recovery, and lower the risk of transfusion shock. Moreover, excessive use of alcohol and recreational drugs and the rising prevalence of diabetes, arthritis, Parkinson's disease, and spinal cord injuries increase the risk of developing hypothermia. This, along with the rising rates of surgical operations and procedures and the aging population, is contributing to the market growth. Additionally, these devices are required in exchange transfusion among infants with cold agglutinin disease. The emerging trend of private medical practice is driving the market further. Apart from this, governing agencies of several countries are expanding their budgets on defense health systems, which is projected to strengthen the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood warmer devices market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, type and end use.
Breakup by Product:
Breakup by Type:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Barkey GmbH & Co. KG, Baxter International Inc., Belmont Medical Technologies, Biegler GmbH, EMIT Corporation, Gentherm Incorporated, Sarstedt AG & Co. KG, Smith’s Medical, The Surgical Company PTM and Vyaire Medical Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Type, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Barkey GmbH & Co. KG, Baxter International Inc., Belmont Medical Technologies, Biegler GmbH, EMIT Corporation, Gentherm Incorporated, Sarstedt AG & Co. KG, Smith’s Medical, The Surgical Company PTM and Vyaire Medical Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at